Cabozantinib has been approved by the FDA for the treatment of a rare thyroid cancer - http://bit.ly/Txq7MO
2:57 PM - 30 Nov 2012
0 replies
1 retweet
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.